MLA
Duran, Charity G, et al. A Proof-of-concept Clinical Study Examining the Nrf2 Activator Sulforaphane Against Neutrophilic Airway Inflammation. BioMed Central, 2016. https://doi.org/10.17615/11jf-dt18
APA
Duran, C., Burbank, A., Mills, K., Duckworth, H., Aleman, M., Kesic, M., Peden, D., Pan, Y., Zhou, H., & Hernandez, M. (2016). A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation. BioMed Central. https://doi.org/10.17615/11jf-dt18
Chicago
Duran, Charity G., Allison J Burbank, Katherine H Mills, Heather R Duckworth, Maria M Aleman, Matthew J Kesic, David Peden et al. 2016. A Proof-Of-Concept Clinical Study Examining the Nrf2 Activator Sulforaphane Against Neutrophilic Airway Inflammation. BioMed Central. https://doi.org/10.17615/11jf-dt18